Clinical Trial Update: Evaluation of Ceftaroline Fosamil Versus a Comparator in Adult Subjects With Community-acquired Bacterial Pneumonia (CABP) With Risk for Methicillin-resistant Staphylococcus Aureus [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating ceftaroline fosamil versus a comparator in adults with community-acquired bacterial pneumonia at risk for MRSA has completed, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Bacterial Pneumonia

Drugs mentioned

• Teflaro (ceftaroline fosamil)

Snippet

Sponsor: Forest Laboratories | Conditions: Infections | Phase 4 | Status: COMPLETED | Results posted: 2016-02-01